Cms Mssp Participation Agreement

Cms Mssp Participation Agreement

(ii) an ACO whose participation contract has been terminated in accordance with the provisions of p. 425.218 or p. 425.220. 2. The contract must be signed by the ACO supplier/supplier and by a person authorized to be committed by the ACO. (2) The agreement must be signed on behalf of the ACO and the ACO participant by persons authorized to engage the ACO or ACO participants. (9) The agreement must require the conclusion of a conclusion procedure after the end or expiry of the contract, which requires the ACO participant to provide all the data necessary to complete the annual assessment of the quality of ACO care and to address other relevant issues. The participation agreement refers to the written agreement covered by the article. 425.208 (a) between the ACO and the CMS and which, with the provisions of that part, regulates the ACO`s participation in the shared management program.

c) the presentation of agreements. The ACO must be used for each ACO participant at the time of the first application, the renewal of the participation agreement and when added to its list of ACO participants in accordance with the agreement. 425.118 submit a participation agreement to the ACO. Agreements can be presented according to the form defined by the provisions of Directive 425.204 (c) (6) or by the form and form defined by the CMS. 4. The agreement must govern the rights and obligations of the ACO participant and the representation of the ACO, including, but not limited to the quality reporting requirements set out in Part F of this section, the notification requirements of recipients set out in section 425.312 and the impact of participation in the shared management program on the ability of the participant and his ACO providers to participate in other Medicare projects or demonstration programs that involve savings. 1. The ACO is the same legal entity as a recent or previous COA that participates in or participates in a performance-based Medicare ACO initiative within the meaning of this section, or who has participated in a second period of agreement for the shared insurance program under a bilateral model. 425.200 (e).

(7) The agreement must allow the ACO to take corrective action against the ACO participant and must require the ACO participant to take corrective action against its ACO suppliers/suppliers, including the imposition of a corrective action plan, refusal to pay incentives, and termination of the ACO participation agreement to address non-compliance with insurance sharing program requirements and other issues identified as related to program integrity, including CMS. (iii) Denunciation of the ACO participation agreement. b) agreements with ACO suppliers/suppliers. ACOs have the opportunity to enter into product and service contracts with their ACO suppliers directly with their ACO suppliers and services that are aligned with the ACO. For the 2017 performance year and subsequent performance years, an ACO agreement with an ACO supplier/provider for these items and services must meet the following criteria: (1) ACO whose participation contract has expired and which immediately takes a new contract term to continue its participation in the program; or (7) The agreement must allow the ACO to take corrective action, including the following action against the ACO supplier/provider, to address non-compliance with shared insurance program requirements and other issues related to the integrity of the program. including those identified by the CMS: (2) Is a new legal entity who has never participated in the shared savings program and applied to participate in the program, and more than 50% of the ACO participants were placed on the ACO participant list in accordance with the ACO list of participants. 425.118 of the same ACO in one of the last 5 years of benefits before the start of the contract. (5) The agreement should describe how the possibility of obtaining common savings or other financial arrangements will encourage ACO participants to comply with the QUALITY assurance and improvement program and evidence-based drug guidelines adopted by the ACO.